News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

J. Jamie Alberty-Oller

Articles by J. Jamie Alberty-Oller

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?

ByAmy Jeng,Cristina Solis-Pomales,Kseniya Roudakova,J. Jamie Alberty-Oller

May 26th 2024

Latest Updated Articles

45 Application of the 7-Gene Biosignature in Palpable Versus Nonpalpable Ductal Carcinoma In Situ in a Black Patient Population: Does Palpability Suggest a More Aggressive Genomic Risk?
Published: May 26th 2024 | Updated:

Trending on CancerNetwork

Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC

Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors

How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap

Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome

BL-B01D1 Shows Preliminary Efficacy, Favorable Safety in Urothelial Cancer

© 2025 MJH Life Sciences^®

All rights reserved.